New cases tested for RR-/MDR-TB in South-East Asia (WHO region)
South-East Asia (WHO region): New cases tested for RR-/MDR-TB was 91.0% in 2024. ◆ Volatile
Latest (2024)
91.0%
Change on year
up 15.2%
Rank
1st
of 11 groups
All-time high
91.0%
in 2024
All-time low
0.1%
in 2005
Years of data
20
2005–2024
New cases tested for RR-/MDR-TB in South-East Asia (WHO region), 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for new cases tested for rr-/mdr-tb in South-East Asia (WHO region) is 91.0%, measured in 2024. That is the highest value across all 20 years on record.
That represents a change of up 15.2% on the previous year and up 1,968.2% over ten years.
Over the whole period, new cases tested for rr-/mdr-tb in South-East Asia (WHO region) peaked at 91.0% in 2024 and was at its lowest, 0.1%, in 2005.
The series is highly variable year to year, so single readings are best treated with caution.
New cases tested for RR-/MDR-TB in South-East Asia (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 0.1% | — |
| 2006 | 0.1% | +0.0% |
| 2007 | 0.2% | +100.0% |
| 2008 | 0.1% | -50.0% |
| 2009 | 0.1% | +10.0% |
| 2010 | 0.1% | +9.1% |
| 2011 | 0.1% | +16.7% |
| 2012 | 0.2% | +35.7% |
| 2013 | 1.4% | +636.8% |
| 2014 | 4.4% | +214.3% |
| 2015 | 11.0% | +150.0% |
| 2016 | 35.0% | +218.2% |
| 2017 | 56.0% | +60.0% |
| 2018 | 45.0% | -19.6% |
| 2019 | 67.0% | +48.9% |
| 2020 | 81.0% | +20.9% |
| 2021 | 68.0% | -16.0% |
| 2022 | 70.0% | +2.9% |
| 2023 | 79.0% | +12.9% |
| 2024 | 91.0% | +15.2% |
Biggest year-on-year movements
Years where New cases tested for RR-/MDR-TB in South-East Asia (WHO region) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2013 | +636.8% | 0.2% | 1.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.1% | 0.1% | 0.2% | 5 |
| 2010s | 22.0% | 0.1% | 67.0% | 10 |
| 2020s | 77.8% | 68.0% | 91.0% | 5 |
Countries ranked near South-East Asia (WHO region)
- 1 Brunei Darussalam 100.0% compare
- 1 Fiji 100.0% compare
- 1 Seychelles 100.0% compare
- 1 Chile 100.0% compare
- 1 Montenegro 100.0% compare
- 1 Mauritius 100.0% compare
- 1 Slovenia 100.0% compare
- 1 Ecuador 100.0% compare
- 1 Barbados 100.0% compare
- 1 Eswatini 100.0% compare
- 1 Qatar 100.0% compare
- 1 Zimbabwe 100.0% compare
- 1 Bangladesh 100.0% compare
- 1 Lao People's Democratic Republic 100.0% compare
- 1 Armenia 100.0% compare
- 1 Iraq 100.0% compare
- 1 Costa Rica 100.0% compare
- 1 Albania 100.0% compare
- 1 Kuwait 100.0% compare
- 1 Oman 100.0% compare
- 1 Iceland 100.0% compare
- 1 Palau 100.0% compare
- 1 Bhutan 100.0% compare
- 1 New Zealand 100.0% compare
- 1 Afghanistan 100.0% compare
- 1 Benin 100.0% compare
- 1 Republic of Moldova 100.0% compare
- 1 Marshall Islands 100.0% compare
- 1 Belarus 100.0% compare
- 1 Samoa 100.0% compare
- 1 Lithuania 100.0% compare
- 1 Turkmenistan 100.0% compare
- 1 Jamaica 100.0% compare
- 1 Korea 100.0% compare
- 1 Morocco 100.0% compare
- 1 Belize 100.0% compare
- 1 Israel 100.0% compare
- 1 Antigua and Barbuda 100.0% compare
- 1 Eritrea 100.0% compare
- 1 Tonga 100.0% compare
- 1 Grenada 100.0% compare
- 1 Kazakhstan 100.0% compare
- 1 Ghana 100.0% compare
- 1 Togo 100.0% compare
- 1 Saint Vincent and the Grenadines 100.0% compare
- 1 Comoros 100.0% compare
- 1 Naoero 100.0% compare
- 1 Djibouti 100.0% compare
- 1 Saint Kitts and Nevis 100.0% compare
More health data for South-East Asia (WHO region)
- Pertussis - number of reported cases, gaps filled 2,449 (2025)
- Total tetanus - number of reported cases, gaps filled 164 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 84 (2025)
- Measles - number of reported cases, gaps filled 19,075 (2025)
- Diphtheria - number of reported cases, gaps filled 3,416 (2025)
- Number of under-five deaths, annual growth rate -4.64 % change on previous year (2024)
- Number of neonatal deaths, annual growth rate -4.57 % change on previous year (2024)
- Number of infant deaths, annual growth rate -4.21 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate -30.44 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -67.98 % change on previous year (2025)
Frequently asked questions
- What is new cases tested for rr-/mdr-tb in South-East Asia (WHO region)?
- New cases tested for rr-/mdr-tb in South-East Asia (WHO region) was 91.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest new cases tested for rr-/mdr-tb recorded in South-East Asia (WHO region)?
- The highest recorded value was 91.0% in 2024.
- What is the lowest new cases tested for rr-/mdr-tb recorded in South-East Asia (WHO region)?
- The lowest recorded value was 0.1% in 2005.
- How does South-East Asia (WHO region) rank for new cases tested for rr-/mdr-tb?
- South-East Asia (WHO region) ranks 1st out of 11 groups with data for 2024.
- Is new cases tested for rr-/mdr-tb rising or falling in South-East Asia (WHO region)?
- Over the last ten years it is up 1,968.2%. The long-run trend across the full record is volatile.
- Where does this South-East Asia (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of New cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).